Industries > Pharma > Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031
Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031
Forecasts by Molecule Type (Small Molecule, Large Molecule), by Type (Monoclonal Antibodies (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics, Others), by Application (Cancer, Diabetes, Cardiovascular Diseases, CNS, Infectious, Others), by Container Type (Bottles, Ampoules, Vials, Pre-filled Syringes, Bags), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), Others), by Service (Bioanalytical Testing, Method Development & Validation, Stability Testing, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios
As CMOs become Integrated into Pharmaceutical Businesses’ Value Chains, This Business Model is Projected to be a Resounding Success
As an alternative to pharmaceutical corporations’ in-house research and production divisions, contract manufacturing organisations (CMOs) have emerged in the last several decades. As contract manufacturing organisations (CMOs) become more and more integrated into pharmaceutical businesses’ value chains, this business model is proving to be a resounding success. The industry as a whole is growing, but many CMOs are having to deal with difficulties they have never faced before. Because of intense competition, rising costs, ongoing technical advancements, and an increase in merger and acquisition activity, businesses are forced to consider what actions they might take to protect or enhance their position in this competitive market.
CMO of Sterile Injectable Drugs Market Growth Drivers
• Outsourced biologic drug product production capabilities
• High growth in developing markets
• Lucrative demand for biologics
• More sterile injectable drugs are losing their patents, including biologics, and the generic parenteral and biosimilar markets are growing
• Increased demand for patient-friendly parenteral administration methods and prefilled syringes
• The ageing population and the ailments that come with it (cancer, diabetes, autoimmune, metabolic, nervous system disorders, etc.)
• High-potency (HPAPI and cytotoxic) medicinal product production
• Adding second-source drug product manufacturers to the supply chain reduces supply chain risk
What Factors Are Challenging Market Growth
• Capabilities in analytical development and/or testing
• Identifying CMOs with ADC filling capability
• Available sterile filling capacity for modest amounts
• Visual inspection
• Assay transfer
What are the Market Opportunities?
• Emerging business segments and economies
• India is a favorable sourcing destination for injectables
• Increasing outsourcing activities by major pharmaceutical companies towards emerging markets for cost savings
Discover how to stay ahead
Our 520+ page report provides 680+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market. See how to exploit the opportunities.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
To access the data contained in this document please email contactus@visiongain.com
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter’s Five Forces, SWOT Analysis, product profiles and commercial developments.
Discover sales predictions for the world market and sub-markets
Molecule Type
• Small Molecule
• Large Molecule
Type
• Monoclonal Antibodies (mAbs)
• Cytokines
• Insulin
• Peptide Hormones
• Vaccines
• Immunoglobulins
• Blood Factors
• Peptide Antibiotics
• Others
Application
• Cancer
• Diabetes
• Cardiovascular Diseases
• CNS
• Infectious
• Others
Container Type
• Bottles
• Ampoules
• Vials
• Prefilled Syringes
• Bags
Route of Administration
• Subcutaneous (SC)
• Intravenous (IV)
• Intramuscular (IM)
• Others
Service
• Bioanalytical Testing
• Method Development & Validation
• Stability Testing
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:
By Region
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South-East Asia
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
Need industry data? Please contact us today.
Leading companies and the potential for market growth
Overall world revenue for contract manufacturing outsourcing (CMO) of sterile injectable drugs Market will surpass $xx billion in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
Prospects for established firms and those seeking to enter the market– including company profiles for 17 of the major companies involved in the contract manufacturing outsourcing (CMO) of sterile injectable drugs market. Some of the companies profiled in this report include Aenova Group, Almac Group, Baxter Biopharma Solutions, Boehringer Ingelheim, Catalent, Inc., CordenPharma, Evonik Industries AG, Famar Health Care Services, Fresenius Kabi Ag, Grifols SA, Hikma Pharmaceuticals PLC, Jubilant Pharmova Limited, Lonza, Patheon, Inc. (Thermo Fischer), Pfizer CentreOne, Recipharm AB, and Siegfried Holding AG among other prominent players.
How the Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market report helps you
In summary, our 500+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market, with forecasts for 2 molecule types, 8 types, 6 applications, 5 container types, 4 route of administration, and 4 services, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 17 key national markets– See forecasts for the Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs market in North America, Europe, Asia Pacific, and Rest of the World. These regional markets have been further bifurcated by countries including US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, South Korea, and South-East Asia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 17 of the companies involved in the Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market. Some of the company’s profiled in this report include Aenova Group, Almac Group, Baxter Biopharma Solutions, Boehringer Ingelheim, Catalent, Inc., CordenPharma, Evonik Industries AG, Famar Health Care Services, Fresenius Kabi Ag, Grifols SA, Hikma Pharmaceuticals PLC, Jubilant Pharmova Limited, Lonza, Patheon, Inc. (Thermo Fischer), Pfizer CentreOne, Recipharm AB, and Siegfried Holding AG among other prominent players.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market and leading companies. You will find data, trends, and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031: Forecasts by Molecule Type (Small Molecule, Large Molecule), by Type (Monoclonal Antibodies (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics, Others), by Application (Cancer, Diabetes, Cardiovascular Diseases, CNS, Infectious, Others), by Container Type (Bottles, Ampoules, Vials, Pre-filled Syringes, Bags), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), Others), by Service (Bioanalytical Testing, Method Development & Validation, Stability Testing, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction to CMO of Sterile Injectable Drugs Market
1.2 CMO of Sterile Injectable Drugs Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 More sterile injectable drugs are losing their patents, including biologics, and the generic parenteral and biosimilar markets are growing
3.1.2 Lucrative demand for biologics
3.1.3 The ageing population and the ailments that come with it (cancer, diabetes, autoimmune, metabolic, nervous system disorders, etc.)
3.2 Restraints
3.2.1 Capabilities in analytical development and testing
3.2.2 Available sterile filling capacity for modest amounts anticipated to restrain market growth
3.3 Opportunities
3.3.1 Emerging business segments and economies
3.3.2 Increasing outsourcing activities by major pharmaceutical companies towards emerging markets for cost savings
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weaknesses
3.4.3 Opportunities
3.4.4 Threats
3.5 Porter’s Five Forces Analysis
3.5.1 Buyer Power
3.5.2 Supplier Power
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitute
3.5.5 Threat of New Entrants
3.6 PEST Analysis
3.6.1 Political Factors Impacting CMO of Sterile Injectable Drugs Market
3.6.2 Economic Factors Impacting CMO of Sterile Injectable Drugs Market
3.6.3 Social Factors Impacting CMO of Sterile Injectable Drugs Market
3.6.4 Technological Factors Impacting CMO of Sterile Injectable Drugs Market
4 CMO of Sterile Injectable Drugs Market by Molecule Type
4.1 Small Molecule Segment Market Forecast, 2021-2031
4.1.1 Small Molecules Segment Market Overview
4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Large Molecule Segment Market Forecast, 2021-2031
4.2.1 Large Molecules Segment Market Overview
4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 CMO of Sterile Injectable Drugs Market by Type
5.1 Monoclonal Antibodies (mAbs) Segment Market Forecast, 2021-2031
5.1.1 Monoclonal Antibodies (mAbs) Segment Market Overview
5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 Cytokines Segment Market Forecast, 2021-2031
5.2.1 Cytokines Segment Market Overview
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.3 Insulin Segment Market Forecast, 2021-2031
5.3.1 Insulin Segment Market Overview
5.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.4 Peptide Hormones Segment Market Forecast, 2021-2031
5.4.1 Peptide Hormones Segment Market Overview
5.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.5 Vaccines Segment Market Forecast, 2021-2031
5.5.1 Vaccines Segment Market Overview
5.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.6 Immunoglobulins Segment Market Forecast, 2021-2031
5.6.1 Immunoglobulins Segment Market Overview
5.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.7 Blood Factors Segment Market Forecast, 2021-2031
5.7.1 Blood Factors Segment Market Overview
5.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.8 Peptide Antibiotics Segment Market Forecast, 2021-2031
5.8.1 Peptide Antibiotics Segment Market Overview
5.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.9 Others Segment Market Forecast, 2021-2031
5.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 CMO of Sterile Injectable Drugs Market by Application
6.1 Cancer Segment Market Forecast, 2021-2031
6.1.1 Cancer Segment Market Overview
6.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.2 Diabetes Segment Market Forecast, 2021-2031
6.2.1 Diabetes Segment Market Overview
6.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.3 Cardiovascular Diseases Segment Market Forecast, 2021-2031
6.3.1 Cardiovascular Diseases Segment Market Overview
6.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.4 CNS Segment Market Forecast, 2021-2031
6.4.1 CNS Segment Market Overview
6.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.5 Infectious Segment Market Forecast, 2021-2031
6.5.1 Infectious Segment Market Overview
6.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.6 Others Segment Market Forecast, 2021-2031
6.6.1 Others Segment Market Overview
6.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 CMO of Sterile Injectable Drugs Market by Container Type
7.1 Bottles Segment Market Forecast, 2021-2031
7.1.1 Bottles Segment Market Overview
7.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.2 Ampoules Segment Market Forecast, 2021-2031
7.2.1 Ampoules Segment Market Overview
7.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.3 Vials Segment Market Forecast, 2021-2031
7.3.1 Vials Segment Market Overview
7.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.4 Prefilled Syringes Segment Market Forecast, 2021-2031
7.4.1 Prefilled Syringes Segment Market Overview
7.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.5 Bags Segment Market Forecast, 2021-2031
7.5.1 Bags Segment Revenue, 2021-2031
7.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8 CMO of Sterile Injectable Drugs Market by Route of Administration
8.1 Subcutaneous (SC) Segment Market Forecast, 2021-2031
8.1.1 Subcutaneous (SC) Segment Revenue, 2021-2031
8.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8.2 Intravenous (IV) Segment Market Forecast, 2021-2031
8.2.1 Intravenous (IV) Segment Revenue, 2021-2031
8.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8.3 Intramuscular (IM) Segment Market Forecast, 2021-2031
8.3.1 Intramuscular Segment Revenue, 2021-2031
8.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8.4 Others Segment Market Forecast, 2021-2031
8.4.1 Others Segment Revenue, 2021-2031
8.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9 CMO of Sterile Injectable Drugs Market by Service
9.1 Bioanalytical Testing Segment Market Forecast, 2021-2031
9.1.1 Bioanalytical Testing Segment Revenue, 2021-2031
9.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9.2 Method Development & Validation Segment Market Forecast, 2021-2031
9.2.1 Method Development & Validation Segment Revenue, 2021-2031
9.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9.3 Stability Testing Segment Market Forecast, 2021-2031
9.3.1 Stability Testing Segment Revenue, 2021-2031
9.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9.4 Others Segment Market Forecast, 2021-2031
9.4.1 Others Segment Revenue, 2021-2031
9.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
10 Regional and Leading National CMO of Sterile Injectable Drugs Market Forecasts 2021-2031
10.1 Global CMO of Sterile Injectable Drugs Market by Region Forecast 2021-2031
10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
11 North America CMO of Sterile Injectable Drugs Market
11.1 North American CMO of Sterile Injectables Market Outlook
11.2 North America CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
11.3 North America CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
11.4 North America CMO of Sterile Injectable Drugs Market Forecast by Type
11.5 North America CMO of Sterile Injectable Drugs Market Forecast by Application
11.6 North America CMO of Sterile Injectable Drugs Market Forecast by Container Type
11.7 North America CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
11.8 North America CMO of Sterile Injectable Drugs Market Forecast by Service
11.9 U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
11.9.1 U.S. CMO of Sterile Injectables Market Outlook
11.9.2 U.S. CMO of Sterile Injectables Market Revenue, 2021-2031
11.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
11.10 Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
11.10.1 Canada CMO of Sterile Injectables Market Outlook
11.10.2 Canada CMO of Sterile Injectables Market Revenue, 2021-2031
11.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12 Europe CMO of Sterile Injectable Drugs Market
12.1 European CMO of Sterile Injectables Market Outlook
12.2 Europe CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
12.3 Europe CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
12.4 Europe CMO of Sterile Injectable Drugs Market Forecast by Type
12.5 Europe CMO of Sterile Injectable Drugs Market Forecast by Application
12.6 Europe CMO of Sterile Injectable Drugs Market Forecast by Container Type
12.7 Europe CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
12.8 Europe CMO of Sterile Injectable Drugs Market Forecast by Service
12.9 Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.9.1 Germany CMO of Sterile Injectables Market Outlook
12.9.2 Germany CMO of Sterile Injectables Market Revenue, 2021-2031
12.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.10 UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.10.1 UK CMO of Sterile Injectables Market Outlook
12.10.2 UK CMO of Sterile Injectables Market Revenue, 2021-2031
12.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.11 France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.11.1 France CMO of Sterile Injectables Market Outlook
12.11.2 France CMO of Sterile Injectables Market Revenue, 2021-2031
12.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.12 Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.12.1 Italy CMO of Sterile Injectables Market Outlook
12.12.2 Italy CMO of Sterile Injectables Market Revenue, 2021-2031
12.12.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.13 Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.13.1 Spain CMO of Sterile Injectables Market Outlook
12.13.2 Spain CMO of Sterile Injectables Market Revenue, 2021-2031
12.13.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.14 Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.14.1 Russia CMO of Sterile Injectables Market Outlook
12.14.2 Russia CMO of Sterile Injectables Market Revenue, 2021-2031
12.14.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.15 Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.15.1 Rest of Europe CMO of Sterile Injectables Market Outlook
12.15.2 Rest of Europe CMO of Sterile Injectables Market Revenue, 2021-2031
12.15.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13 Asia Pacific CMO of Sterile Injectable Drugs Market
13.1 Asia Pacific CMO of Sterile Injectables Market Outlook
13.2 Asia Pacific CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
13.3 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
13.4 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Type
13.5 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Application
13.6 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Container Type
13.7 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
13.8 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Service
13.9 Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.9.1 Japan CMO of Sterile Injectables Market Outlook
13.9.2 Japan CMO of Sterile Injectables Market Revenue, 2021-2031
13.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.10 China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.10.1 China CMO of Sterile Injectables Market Outlook
13.10.2 China CMO of Sterile Injectables Market Revenue, 2021-2031
13.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.11 India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.11.1 India CMO of Sterile Injectables Market Outlook
13.11.2 India CMO of Sterile Injectables Market Revenue, 2021-2031
13.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.12 Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.12.1 Australia CMO of Sterile Injectables Market Outlook
13.12.2 Australia CMO of Sterile Injectables Market Revenue, 2021-2031
13.12.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.13 South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.13.1 South-East Asia CMO of Sterile Injectables Market Revenue, 2021-2031
13.13.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.14 Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.14.1 Rest of Asia Pacific CMO of Sterile Injectables Market Outlook
13.14.2 Rest of Asia Pacific CMO of Sterile Injectables Market Revenue, 2021-2031
13.14.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14 Latin America CMO of Sterile Injectable Drugs Market
14.1 Latin American CMO of Sterile Injectables Market Outlook
14.2 Latin America CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
14.3 Latin America CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
14.4 Latin America CMO of Sterile Injectable Drugs Market Forecast by Type
14.5 Latin America CMO of Sterile Injectable Drugs Market Forecast by Application
14.6 Latin America CMO of Sterile Injectable Drugs Market Forecast by Container Type
14.7 Latin America CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
14.8 Latin America CMO of Sterile Injectable Drugs Market Forecast by Service
14.9 Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.9.1 Brazil CMO of Sterile Injectables Market Outlook
14.9.2 Brazil CMO of Sterile Injectables Market Revenue, 2021-2031
14.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.10 Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.10.1 Mexico CMO of Sterile Injectables Market Outlook
14.10.2 Mexico CMO of Sterile Injectables Market Revenue, 2021-2031
14.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.11 Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.11.1 Rest of Latin America CMO of Sterile Injectables Market Outlook
14.11.2 Rest of Latin America CMO of Sterile Injectables Market Revenue, 2021-2031
14.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15 Middle East and Africa CMO of Sterile Injectable Drugs Market
15.1 Middle East and Africa CMO of Sterile Injectables Market Outlook
15.2 Middle East and Africa CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
15.3 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
15.4 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Type
15.5 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Application
15.6 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Container Type
15.7 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
15.8 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Service
15.9 GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.9.1 GCC CMO of Sterile Injectables Market Outlook
15.9.2 GCC CMO of Sterile Injectables Market Revenue, 2021-2031
15.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.10 South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.10.1 South Africa CMO of Sterile Injectables Market Outlook
15.10.2 South Africa CMO of Sterile Injectables Market Revenue, 2021-2031
15.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.11 Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.11.1 Rest of MEA CMO of Sterile Injectables Market Outlook
15.11.2 Rest of MEA CMO of Sterile Injectables Market Revenue, 2021-2031
15.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
16 Company Profiles
16.1 Aenova Group
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Product Benchmarking
16.1.4 Recent Developments
16.2 Almac Group
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments
16.3 Baxter Biopharma Solutions
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.4 Product Benchmarking
16.3.5 Recent Developments
16.4 Boehringer Ingelheim
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.4 Product Benchmarking
16.5 Catalent, Inc.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Financial Analysis
16.5.4 Product Benchmarking
16.5.5 Recent Developments
16.6 CordenPharma
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Product Benchmarking
16.6.4 Recent Developments
16.7 Evonik Industries AG
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.4 Product Benchmarking
16.8 Famar Health Care Services
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Product Benchmarking
16.9 Fresenius Kabi Ag
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Financial Analysis
16.9.4 Product Benchmarking
16.10 Grifols SA
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.4 Product Benchmarking
16.10.5 Recent Developments
16.11 Hikma Pharmaceuticals PLC
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.4 Product Benchmarking
16.11.5 Recent Developments
16.12 Jubilant Pharmova Limited
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Financial Analysis
16.12.4 Product Benchmarking
16.13 Lonza
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Financial Analysis
16.13.4 Product Benchmarking
16.13.5 Recent Developments
16.14 Patheon, Inc. (Thermo Fischer)
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Financial Analysis
16.14.4 Product Benchmarking
16.15 Pfizer CentreOne
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Financial Analysis
16.15.4 Product Benchmarking
16.16 Recipharm AB
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Product Benchmarking
16.16.4 Recent Developments
16.17 Siegfried Holding AG
16.17.1 Company Snapshot
16.17.2 Company Overview
16.17.3 Financial Analysis
16.17.4 Product Benchmarking
17 Conclusion and Recommendations
17.1 Concluding Remarks
17.2 Recommendations
List of Tables
Table 1 Global CMO of Sterile Injectable Drugs Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global CMO of Sterile Injectables Market Forecast by Molecule Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 4 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 9 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global CMO of Sterile Injectables Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 14 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 15 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 16 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 17 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 18 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 19 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 20 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 25 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 30 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 31 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 32 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 33 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 34 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 35 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 36 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 37 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 38 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 39 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 40 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 41 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 42 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 43 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 44 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 45 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 46 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 47 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 48 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 49 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 50 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 51 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 52 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 53 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 54 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 55 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 56 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Global CMO of Sterile Injectables Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 60 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 61 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 62 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 63 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 64 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 65 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 66 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 67 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 68 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 69 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 70 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 71 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 72 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 73 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 74 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 75 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 76 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 77 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 78 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 79 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 80 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 81 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 82 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 83 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 84 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 85 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 86 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 87 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 88 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 89 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 90 Global CMO of Sterile Injectables Market Forecast by Container Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 91 Global CMO of Sterile Injectables Market Forecast for Bottles Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 92 Global CMO of Sterile Injectables Market Forecast for Bottles Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 93 Global CMO of Sterile Injectables Market Forecast for Bottles Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 94 Global CMO of Sterile Injectables Market Forecast for Bottles Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 95 Global CMO of Sterile Injectables Market Forecast for Bottles Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 96 Global CMO of Sterile Injectables Market Forecast for Ampoules Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 97 Global CMO of Sterile Injectables Market Forecast for Ampoules Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 98 Global CMO of Sterile Injectables Market Forecast for Ampoules Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 99 Global CMO of Sterile Injectables Market Forecast for Ampoules Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 100 Global CMO of Sterile Injectables Market Forecast for Ampoules Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 101 Global CMO of Sterile Injectables Market Forecast for Vials Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 102 Global CMO of Sterile Injectables Market Forecast for Vials Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 103 Global CMO of Sterile Injectables Market Forecast for Vials Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 104 Global CMO of Sterile Injectables Market Forecast for Vials Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 105 Global CMO of Sterile Injectables Market Forecast for Vials Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 106 Global CMO of Sterile Injectables Market Forecast for Prefilled Syringes Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 107 Global CMO of Sterile Injectables Market Forecast for Prefilled Syringes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 108 Global CMO of Sterile Injectables Market Forecast for Prefilled Syringes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 109 Global CMO of Sterile Injectables Market Forecast for Prefilled Syringes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 110 Global CMO of Sterile Injectables Market Forecast for Prefilled Syringes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 111 Global CMO of Sterile Injectables Market Forecast for Bags Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 112 Global CMO of Sterile Injectables Market Forecast for Bags Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 113 Global CMO of Sterile Injectables Market Forecast for Bags Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 114 Global CMO of Sterile Injectables Market Forecast for Bags Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 115 Global CMO of Sterile Injectables Market Forecast for Bags Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 116 Global CMO of Sterile Injectables Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 117 Global CMO of Sterile Injectables Market Forecast for Subcutaneous (SC) Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 118 Global CMO of Sterile Injectables Market Forecast for Subcutaneous (SC) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 119 Global CMO of Sterile Injectables Market Forecast for Subcutaneous (SC) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 120 Global CMO of Sterile Injectables Market Forecast for Subcutaneous (SC) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 121 Global CMO of Sterile Injectables Market Forecast for Subcutaneous (SC) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 122 Global CMO of Sterile Injectables Market Forecast for Intravenous (IV) Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 123 Global CMO of Sterile Injectables Market Forecast for Intravenous (IV) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 124 Global CMO of Sterile Injectables Market Forecast for Intravenous (IV) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 125 Global CMO of Sterile Injectables Market Forecast for Intravenous (IV) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 126 Global CMO of Sterile Injectables Market Forecast for Intravenous (IV) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 127 Global CMO of Sterile Injectables Market Forecast for Intramuscular (IM) Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 128 Global CMO of Sterile Injectables Market Forecast for Intramuscular (IM) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 129 Global CMO of Sterile Injectables Market Forecast for Intramuscular (IM) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 130 Global CMO of Sterile Injectables Market Forecast for Intramuscular (IM) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 131 Global CMO of Sterile Injectables Market Forecast for Intramuscular (IM) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 132 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 133 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 134 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 135 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 136 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 137 Global CMO of Sterile Injectables Market Forecast by Service, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 138 Global CMO of Sterile Injectables Market Forecast for Bioanalytical Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 139 Global CMO of Sterile Injectables Market Forecast for Bioanalytical Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 140 Global CMO of Sterile Injectables Market Forecast for Bioanalytical Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 141 Global CMO of Sterile Injectables Market Forecast for Bioanalytical Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 142 Global CMO of Sterile Injectables Market Forecast for Bioanalytical Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 143 Global CMO of Sterile Injectables Market Forecast for Method Development & Validation Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 144 Global CMO of Sterile Injectables Market Forecast for Method Development & Validation Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 145 Global CMO of Sterile Injectables Market Forecast for Method Development & Validation Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 146 Global CMO of Sterile Injectables Market Forecast for Method Development & Validation Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 147 Global CMO of Sterile Injectables Market Forecast for Method Development & Validation Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 148 Global CMO of Sterile Injectables Market Forecast for Stability Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 149 Global CMO of Sterile Injectables Market Forecast for Stability Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 150 Global CMO of Sterile Injectables Market Forecast for Stability Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 151 Global CMO of Sterile Injectables Market Forecast for Stability Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 152 Global CMO of Sterile Injectables Market Forecast for Stability Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 153 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 154 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 155 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 156 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 157 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 158 Global CMO of Sterile Injectables Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%)
Table 159 Global CMO of Sterile Injectables Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 160 Global CMO of Sterile Injectables Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 161 Global CMO of Sterile Injectables Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 162 Global CMO of Sterile Injectables Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 163 North America CMO of Sterile Injectables Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 164 North America CMO of Sterile Injectables Market Forecast by Molecule Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 165 North America CMO of Sterile Injectables Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 166 North America CMO of Sterile Injectables Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 167 North America CMO of Sterile Injectables Market Forecast by Container Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 168 North America CMO of Sterile Injectables Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 169 North America CMO of Sterile Injectables Market Forecast by Service, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 170 U.S. CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 171 U.S. CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 172 U.S. CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 173 U.S. CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 174 U.S. CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 175 Canada CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 176 Canada CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 177 Canada CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 178 Canada CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 179 Canada CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 180 Europe CMO of Sterile Injectables Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 181 Europe CMO of Sterile Injectables Market Forecast by Molecule Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 182 Europe CMO of Sterile Injectables Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 183 Europe CMO of Sterile Injectables Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 184 Europe CMO of Sterile Injectables Market Forecast by Container Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 185 Europe CMO of Sterile Injectables Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 186 Europe CMO of Sterile Injectables Market Forecast by Service, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 187 Germany CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 188 Germany CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 189 Germany CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 190 Germany CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 191 Germany CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 192 UK CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 193 UK CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 194 UK CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 195 UK CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 196 France CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 197 France CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 198 France CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 199 France CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 200 France CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 201 France CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 202 Italy CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 203 Italy CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 204 Italy CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 205 Italy CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 206 Italy CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 207 Spain CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 208 Spain CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 209 Spain CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 210 Spain CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 211 Spain CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 212 Russia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 213 Russia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 214 Russia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 215 Russia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 216 Russia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 217 Rest of Europe CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 218 Rest of Europe CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 219 Rest of Europe CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 220 Rest of Europe CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 221 Rest of Europe CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 222 Asia Pacific CMO of Sterile Injectables Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 223 Asia Pacific CMO of Sterile Injectables Market Forecast by Molecule Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 224 Asia Pacific CMO of Sterile Injectables Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 225 Asia Pacific CMO of Sterile Injectables Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 226 Asia Pacific CMO of Sterile Injectables Market Forecast by Container Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 227 Asia Pacific CMO of Sterile Injectables Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 228 Asia Pacific CMO of Sterile Injectables Market Forecast by Service, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 229 Japan CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 230 Japan CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 231 Japan CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 232 Japan CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 233 Japan CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 234 China CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 235 China CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 236 China CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 237 China CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 238 China CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 239 India CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 240 India CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 241 India CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 242 India CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 243 India CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 244 Australia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 245 Australia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 246 Australia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 247 Australia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 248 Australia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 249 South-East Asia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 250 South-East Asia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 251 South-East Asia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 252 South-East Asia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 253 South-East Asia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 254 Rest of Asia Pacific CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 255 Rest of Asia Pacific CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 256 Rest of Asia Pacific CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 257 Rest of Asia Pacific CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 258 Rest of Asia Pacific CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 259 Latin America CMO of Sterile Injectables Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 260 Latin America CMO of Sterile Injectables Market Forecast by Molecule Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 261 Latin America CMO of Sterile Injectables Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 262 Latin America CMO of Sterile Injectables Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 263 Latin America CMO of Sterile Injectables Market Forecast by Container Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 264 Latin America CMO of Sterile Injectables Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 265 Latin America CMO of Sterile Injectables Market Forecast by Service, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 266 Brazil CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 267 Brazil CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 268 Brazil CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 269 Brazil CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 270 Brazil CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 271 Mexico CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 272 Mexico CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 273 Mexico CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 274 Mexico CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 275 Mexico CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 276 Rest of Latin America CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 277 Rest of Latin America CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 278 Rest of Latin America CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 279 Rest of Latin America CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 280 Rest of Latin America CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 281 MEA CMO of Sterile Injectables Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 282 MEA CMO of Sterile Injectables Market Forecast by Molecule Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 283 MEA CMO of Sterile Injectables Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 284 MEA CMO of Sterile Injectables Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 285 MEA CMO of Sterile Injectables Market Forecast by Container Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 286 MEA CMO of Sterile Injectables Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 287 MEA CMO of Sterile Injectables Market Forecast by Service, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 288 GCC CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 289 GCC CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 290 GCC CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 291 GCC CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 292 GCC CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 293 South Africa CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 294 South Africa CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 295 South Africa CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 296 South Africa CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 297 South Africa CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 298 Rest of MEA CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 299 Rest of MEA CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 300 Rest of MEA CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 301 Rest of MEA CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 302 Rest of MEA CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 303 Aenova Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 304 Aenova Group: Product Benchmarking
Table 305 Aenova Group: Recent Developments
Table 306 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 307 Almac Group: Product Benchmarking
Table 308 Almac Group: Recent Developments
Table 309 Baxter Biopharma Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 310 Baxter Biopharma Solutions: Product Benchmarking
Table 311 Baxter Biopharma Solutions: Recent Developments
Table 312 Boehringer Ingelheim: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 313 Boehringer Ingelheim: Product Benchmarking
Table 314 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 315 Catalent, Inc.: Product Benchmarking
Table 316 Catalent, Inc.: Recent Developments
Table 317 CordenPharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 318 CordenPharma: Product Benchmarking
Table 319 CordenPharma: Recent Developments
Table 320 Evonik Industries AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 321 Evonik Industries AG: Product Benchmarking
Table 322 Famar Health Care Services: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 323 Famar Health Care Services: Product Benchmarking
Table 324 Fresenius Kabi Ag: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 325 Fresenius Kabi Ag: Product Benchmarking
Table 326 Grifols SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 327 Grifols SA: Product Benchmarking
Table 328 Grifols SA: Recent Developments
Table 329 Hikma Pharmaceuticals PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 330 Hikma Pharmaceuticals PLC: Product Benchmarking
Table 331 Hikma Pharmaceuticals PLC: Recent Developments
Table 332 Jubilant Pharmova Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 333 Jubilant Pharmova Limited: Product Benchmarking
Table 334 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 335 Lonza: Product Benchmarking
Table 336 Lonza: Recent Developments
Table 337 Patheon, Inc. (Thermo Fischer): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 338 Patheon, Inc. (Thermo Fischer): Product Benchmarking
Table 339 Pfizer CentreOne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 340 Pfizer CentreOne: Product Benchmarking
Table 341 Recipharm AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 342 Recipharm AB: Product Benchmarking
Table 343 Recipharm AB: Recent Developments
Table 344 Siegfried Holding AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 345 Siegfried Holding AG: Product Benchmarking
List of Figures
Figure 1 Global CMO of Sterile Injectable Drugs Market: Market Segmentation
Figure 2 Global CMO of Sterile Injectable Drugs Market: Market Trends
Figure 3 Global CMO of Sterile Injectable Drugs Market: SWOT Analysis
Figure 4 Porter’s Analysis
Figure 5 PEST Analysis
Figure 6 Global CMO of Sterile Injectable Drugs Market Forecast by Molecule Type, 2021-2031 (US$ million, AGR %)
Figure 7 Global CMO of Sterile Injectable Drugs Market Share Forecast by Molecule Type, 2021, 2026, 2031 (%)
Figure 8 Global CMO of Sterile Injectable Drugs Market for Small Molecule Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 9 Global CMO of Sterile Injectable Drugs Market for Small Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 10 Global CMO of Sterile Injectable Drugs Market for Small Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 11 Global CMO of Sterile Injectable Drugs Market for Small Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 12 Global CMO of Sterile Injectable Drugs Market for Small Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 13 Global CMO of Sterile Injectable Drugs Market for Large Molecule Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 14 Global CMO of Sterile Injectable Drugs Market for Large Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 15 Global CMO of Sterile Injectable Drugs Market for Large Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 16 Global CMO of Sterile Injectable Drugs Market for Large Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 17 Global CMO of Sterile Injectable Drugs Market for Large Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 18 Global CMO of Sterile Injectable Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR %)
Figure 19 Global CMO of Sterile Injectable Drugs Market Share Forecast by Type, 2021, 2026, 2031 (%)
Figure 20 Global CMO of Sterile Injectable Drugs Market for Monoclonal Antibodies (mAbs) Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 21 Global CMO of Sterile Injectable Drugs Market for Monoclonal Antibodies (mAbs) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 22 Global CMO of Sterile Injectable Drugs Market for Monoclonal Antibodies (mAbs) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 23 Global CMO of Sterile Injectable Drugs Market for Monoclonal Antibodies (mAbs) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 24 Global CMO of Sterile Injectable Drugs Market for Monoclonal Antibodies (mAbs) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 25 Global CMO of Sterile Injectable Drugs Market for Cytokines Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 26 Global CMO of Sterile Injectable Drugs Market for Cytokines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 27 Global CMO of Sterile Injectable Drugs Market for Cytokines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 28 Global CMO of Sterile Injectable Drugs Market for Cytokines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 29 Global CMO of Sterile Injectable Drugs Market for Cytokines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 30 Global CMO of Sterile Injectable Drugs Market for Insulin Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 31 Global CMO of Sterile Injectable Drugs Market for Insulin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 32 Global CMO of Sterile Injectable Drugs Market for Insulin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 33 Global CMO of Sterile Injectable Drugs Market for Insulin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 34 Global CMO of Sterile Injectable Drugs Market for Insulin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 35 Global CMO of Sterile Injectable Drugs Market for Peptide Hormones Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 36 Global CMO of Sterile Injectable Drugs Market for Peptide Hormones Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 37 Global CMO of Sterile Injectable Drugs Market for Peptide Hormones Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 38 Global CMO of Sterile Injectable Drugs Market for Peptide Hormones Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 39 Global CMO of Sterile Injectable Drugs Market for Peptide Hormones Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 40 Global CMO of Sterile Injectable Drugs Market for Vaccines Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 41 Global CMO of Sterile Injectable Drugs Market for Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 42 Global CMO of Sterile Injectable Drugs Market for Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 43 Global CMO of Sterile Injectable Drugs Market for Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 44 Global CMO of Sterile Injectable Drugs Market for Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 45 Global CMO of Sterile Injectable Drugs Market for Immunoglobulins Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 46 Global CMO of Sterile Injectable Drugs Market for Immunoglobulins Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 47 Global CMO of Sterile Injectable Drugs Market for Immunoglobulins Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 48 Global CMO of Sterile Injectable Drugs Market for Immunoglobulins Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 49 Global CMO of Sterile Injectable Drugs Market for Immunoglobulins Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 50 Global CMO of Sterile Injectable Drugs Market for Blood Factors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 51 Global CMO of Sterile Injectable Drugs Market for Blood Factors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 52 Global CMO of Sterile Injectable Drugs Market for Blood Factors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 53 Global CMO of Sterile Injectable Drugs Market for Blood Factors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 54 Global CMO of Sterile Injectable Drugs Market for Blood Factors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 55 Global CMO of Sterile Injectable Drugs Market for Peptide Antibiotics Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 56 Global CMO of Sterile Injectable Drugs Market for Peptide Antibiotics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 57 Global CMO of Sterile Injectable Drugs Market for Peptide Antibiotics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 58 Global CMO of Sterile Injectable Drugs Market for Peptide Antibiotics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 59 Global CMO of Sterile Injectable Drugs Market for Peptide Antibiotics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 60 Global CMO of Sterile Injectable Drugs Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 61 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 62 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 63 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 64 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 65 Global CMO of Sterile Injectable Drugs Market Forecast by Application, 2021-2031 (US$ million, AGR %)
Figure 66 Global CMO of Sterile Injectable Drugs Market Share Forecast by Application, 2021, 2026, 2031 (%)
Figure 67 Global CMO of Sterile Injectable Drugs Market for Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 68 Global CMO of Sterile Injectable Drugs Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 69 Global CMO of Sterile Injectable Drugs Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 70 Global CMO of Sterile Injectable Drugs Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 71 Global CMO of Sterile Injectable Drugs Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 72 Global CMO of Sterile Injectable Drugs Market for Diabetes Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 73 Global CMO of Sterile Injectable Drugs Market for Diabetes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 74 Global CMO of Sterile Injectable Drugs Market for Diabetes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 75 Global CMO of Sterile Injectable Drugs Market for Diabetes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 76 Global CMO of Sterile Injectable Drugs Market for Diabetes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 77 Global CMO of Sterile Injectable Drugs Market for Cardiovascular Diseases Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 78 Global CMO of Sterile Injectable Drugs Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 79 Global CMO of Sterile Injectable Drugs Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 80 Global CMO of Sterile Injectable Drugs Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 81 Global CMO of Sterile Injectable Drugs Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 82 Global CMO of Sterile Injectable Drugs Market for CNS Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 83 Global CMO of Sterile Injectable Drugs Market for CNS Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 84 Global CMO of Sterile Injectable Drugs Market for CNS Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 85 Global CMO of Sterile Injectable Drugs Market for CNS Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 86 Global CMO of Sterile Injectable Drugs Market for CNS Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 87 Global CMO of Sterile Injectable Drugs Market for Infectious Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 88 Global CMO of Sterile Injectable Drugs Market for Infectious Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 89 Global CMO of Sterile Injectable Drugs Market for Infectious Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 90 Global CMO of Sterile Injectable Drugs Market for Infectious Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 91 Global CMO of Sterile Injectable Drugs Market for Infectious Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 92 Global CMO of Sterile Injectable Drugs Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 93 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 94 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 95 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 96 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 97 Global CMO of Sterile Injectable Drugs Market Forecast by Container Type, 2021-2031 (US$ million, AGR %)
Figure 98 Global CMO of Sterile Injectable Drugs Market Share Forecast by Container Type, 2021, 2026, 2031 (%)
Figure 99 Global CMO of Sterile Injectable Drugs Market for Bottles Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 100 Global CMO of Sterile Injectable Drugs Market for Bottles Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 101 Global CMO of Sterile Injectable Drugs Market for Bottles Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 102 Global CMO of Sterile Injectable Drugs Market for Bottles Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 103 Global CMO of Sterile Injectable Drugs Market for Bottles Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 104 Global CMO of Sterile Injectable Drugs Market for Ampoules Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 105 Global CMO of Sterile Injectable Drugs Market for Ampoules Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 106 Global CMO of Sterile Injectable Drugs Market for Ampoules Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 107 Global CMO of Sterile Injectable Drugs Market for Ampoules Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 108 Global CMO of Sterile Injectable Drugs Market for Ampoules Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 109 Global CMO of Sterile Injectable Drugs Market for Vials Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 110 Global CMO of Sterile Injectable Drugs Market for Vials Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 111 Global CMO of Sterile Injectable Drugs Market for Vials Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 112 Global CMO of Sterile Injectable Drugs Market for Vials Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 113 Global CMO of Sterile Injectable Drugs Market for Vials Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 114 Global CMO of Sterile Injectable Drugs Market for Prefilled Syringes Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 115 Global CMO of Sterile Injectable Drugs Market for Prefilled Syringes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 116 Global CMO of Sterile Injectable Drugs Market for Prefilled Syringes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 117 Global CMO of Sterile Injectable Drugs Market for Prefilled Syringes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 118 Global CMO of Sterile Injectable Drugs Market for Prefilled Syringes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 119 Global CMO of Sterile Injectable Drugs Market for Bags Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 120 Global CMO of Sterile Injectable Drugs Market for Bags Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 121 Global CMO of Sterile Injectable Drugs Market for Bags Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 122 Global CMO of Sterile Injectable Drugs Market for Bags Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 123 Global CMO of Sterile Injectable Drugs Market for Bags Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 124 Global CMO of Sterile Injectable Drugs Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR %)
Figure 125 Global CMO of Sterile Injectable Drugs Market Share Forecast by Route of Administration, 2021, 2026, 2031 (%)
Figure 126 Global CMO of Sterile Injectable Drugs Market for Subcutaneous (SC) Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 127 Global CMO of Sterile Injectable Drugs Market for Subcutaneous (SC) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 128 Global CMO of Sterile Injectable Drugs Market for Subcutaneous (SC) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 129 Global CMO of Sterile Injectable Drugs Market for Subcutaneous (SC) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 130 Global CMO of Sterile Injectable Drugs Market for Subcutaneous (SC) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 131 Global CMO of Sterile Injectable Drugs Market for Intravenous (IV) Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 132 Global CMO of Sterile Injectable Drugs Market for Intravenous (IV) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 133 Global CMO of Sterile Injectable Drugs Market for Intravenous (IV) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 134 Global CMO of Sterile Injectable Drugs Market for Intravenous (IV) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 135 Global CMO of Sterile Injectable Drugs Market for Intravenous (IV) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 136 Global CMO of Sterile Injectable Drugs Market for Intramuscular (IM) Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 137 Global CMO of Sterile Injectable Drugs Market for Intramuscular (IM) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 138 Global CMO of Sterile Injectable Drugs Market for Intramuscular (IM) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 139 Global CMO of Sterile Injectable Drugs Market for Intramuscular (IM) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 140 Global CMO of Sterile Injectable Drugs Market for Intramuscular (IM) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 141 Global CMO of Sterile Injectable Drugs Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 142 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 143 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 144 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 145 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 146 Global CMO of Sterile Injectable Drugs Market Forecast by Service, 2021-2031 (US$ million, AGR %)
Figure 147 Global CMO of Sterile Injectable Drugs Market Share Forecast by Service, 2021, 2026, 2031 (%)
Figure 148 Global CMO of Sterile Injectable Drugs Market for Bioanalytical Testing Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 149 Global CMO of Sterile Injectable Drugs Market for Bioanalytical Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 150 Global CMO of Sterile Injectable Drugs Market for Bioanalytical Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 151 Global CMO of Sterile Injectable Drugs Market for Bioanalytical Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 152 Global CMO of Sterile Injectable Drugs Market for Bioanalytical Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 153 Global CMO of Sterile Injectable Drugs Market for Method Development & Validation Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 154 Global CMO of Sterile Injectable Drugs Market for Method Development & Validation Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 155 Global CMO of Sterile Injectable Drugs Market for Method Development & Validation Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 156 Global CMO of Sterile Injectable Drugs Market for Method Development & Validation Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 157 Global CMO of Sterile Injectable Drugs Market for Method Development & Validation Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 158 Global CMO of Sterile Injectable Drugs Market for Stability Testing Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 159 Global CMO of Sterile Injectable Drugs Market for Stability Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 160 Global CMO of Sterile Injectable Drugs Market for Stability Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 161 Global CMO of Sterile Injectable Drugs Market for Stability Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 162 Global CMO of Sterile Injectable Drugs Market for Stability Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 163 Global CMO of Sterile Injectable Drugs Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 164 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 165 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 166 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 167 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 168 Global CMO of Sterile Injectable Drugs Market Forecast by Region 2021-2031 (US$ million)
Figure 169 Global CMO of Sterile Injectable Drugs Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 170 Global CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 171 Global CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 172 Global CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 173 Global CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 174 North America CMO of Sterile Injectable Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 175 North America CMO of Sterile Injectable Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 176 North America CMO of Sterile Injectable Drugs Market Forecast by Molecule Type, 2021-2031 (US$ million, AGR%)
Figure 177 North America CMO of Sterile Injectable Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 178 North America CMO of Sterile Injectable Drugs Market Forecast by Application, 2021-2031 (US$ million, AGR%)
Figure 179 North America CMO of Sterile Injectable Drugs Market Forecast by Container Type, 2021-2031 (US$ million, AGR%)
Figure 180 North America CMO of Sterile Injectable Drugs Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 181 North America CMO of Sterile Injectable Drugs Market Forecast by Service, 2021-2031 (US$ million, AGR%)
Figure 182 U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 183 U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 184 U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 185 U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 186 U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 187 Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 188 Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 189 Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 190 Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 191 Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 192 Europe CMO of Sterile Injectable Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 193 Europe CMO of Sterile Injectable Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 194 Europe CMO of Sterile Injectable Drugs Market Forecast by Molecule Type, 2021-2031 (US$ million, AGR%)
Figure 195 Europe CMO of Sterile Injectable Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 196 Europe CMO of Sterile Injectable Drugs Market Forecast by Application, 2021-2031 (US$ million, AGR%)
Figure 197 Europe CMO of Sterile Injectable Drugs Market Forecast by Container Type, 2021-2031 (US$ million, AGR%)
Figure 198 Europe CMO of Sterile Injectable Drugs Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 199 Europe CMO of Sterile Injectable Drugs Market Forecast by Service, 2021-2031 (US$ million, AGR%)
Figure 200 Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 201 Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 202 Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 203 Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 204 Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 205 UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 206 UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 207 UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 208 UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 209 UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 210 France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 211 France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 212 France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 213 France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 214 France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 215 Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 216 Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 217 Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 218 Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 219 Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 220 Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 221 Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 222 Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 223 Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 224 Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 225 Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 226 Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 227 Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 228 Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 229 Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 230 Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 231 Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 232 Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 233 Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 234 Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 235 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 236 Asia Pacific CMO of Sterile Injectable Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 237 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Molecule Type, 2021-2031 (US$ million, AGR%)
Figure 238 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 239 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Application, 2021-2031 (US$ million, AGR%)
Figure 240 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Container Type, 2021-2031 (US$ million, AGR%)
Figure 241 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 242 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Service, 2021-2031 (US$ million, AGR%)
Figure 243 Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 244 Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 245 Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 246 Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 247 Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 248 China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 249 China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 250 China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 251 China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 252 China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 253 India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 254 India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 255 India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 256 India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 257 India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 258 Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 259 Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 260 Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 261 Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 262 Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 263 South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 264 South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 265 South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 266 South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 267 South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 268 Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 269 Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 270 Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 271 Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 272 Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 273 Latin America CMO of Sterile Injectable Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 274 Latin America CMO of Sterile Injectable Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 275 Latin America CMO of Sterile Injectable Drugs Market Forecast by Molecule Type, 2021-2031 (US$ million, AGR%)
Figure 276 Latin America CMO of Sterile Injectable Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 277 Latin America CMO of Sterile Injectable Drugs Market Forecast by Application, 2021-2031 (US$ million, AGR%)
Figure 278 Latin America CMO of Sterile Injectable Drugs Market Forecast by Container Type, 2021-2031 (US$ million, AGR%)
Figure 279 Latin America CMO of Sterile Injectable Drugs Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 280 Latin America CMO of Sterile Injectable Drugs Market Forecast by Service, 2021-2031 (US$ million, AGR%)
Figure 281 Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 282 Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 283 Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 284 Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 285 Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 286 Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 287 Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 288 Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 289 Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 290 Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 291 Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 292 Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 293 Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 294 Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 295 Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 296 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 297 Middle East and Africa CMO of Sterile Injectable Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 298 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Molecule Type, 2021-2031 (US$ million, AGR%)
Figure 299 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 300 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Application, 2021-2031 (US$ million, AGR%)
Figure 301 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Container Type, 2021-2031 (US$ million, AGR%)
Figure 302 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 303 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Service, 2021-2031 (US$ million, AGR%)
Figure 304 GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 305 GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 306 GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 307 GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 308 GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 309 South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 310 South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 311 South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 312 South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 313 South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 314 Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 315 Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 316 Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 317 Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 318 Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 319 Baxter Biopharma Solutions: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 320 Baxter Biopharma Solutions: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 321 Baxter Biopharma Solutions: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 322 Boehringer Ingelheim: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 323 Boehringer Ingelheim: R&D Expenses, 2017-2020 (US$ million, AGR%)
Figure 324 Boehringer Ingelheim: Gross Profit, 2017-2020 (US$ million, AGR%)
Figure 325 Catalent, Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 326 Catalent, Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 327 Evonik Industries AG: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 328 Evonik Industries AG: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 329 Fresenius Kabi Ag: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 330 Fresenius Kabi Ag: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 331 Fresenius Kabi Ag: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 332 Grifols SA: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 333 Grifols SA: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 334 Grifols SA: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 335 Hikma Pharmaceuticals PLC: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 336 Hikma Pharmaceuticals PLC: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 337 Hikma Pharmaceuticals PLC: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 338 Jubilant Pharmova Limited: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 339 Lonza: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 340 Lonza: R&D Expenses, 2017-2020 (US$ million, AGR%)
Figure 341 Lonza: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 342 Patheon, Inc. (Thermo Fischer): Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 343 Patheon, Inc. (Thermo Fischer): R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 344 Patheon, Inc. (Thermo Fischer): Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 345 Pfizer CentreOne: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 346 Pfizer CentreOne: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 347 Pfizer CentreOne: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 348 Siegfried Holding AG: Net Revenue, 2017-2020 (US$ million, AGR%)
1.1 Introduction to CMO of Sterile Injectable Drugs Market
1.2 CMO of Sterile Injectable Drugs Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 More sterile injectable drugs are losing their patents, including biologics, and the generic parenteral and biosimilar markets are growing
3.1.2 Lucrative demand for biologics
3.1.3 The ageing population and the ailments that come with it (cancer, diabetes, autoimmune, metabolic, nervous system disorders, etc.)
3.2 Restraints
3.2.1 Capabilities in analytical development and testing
3.2.2 Available sterile filling capacity for modest amounts anticipated to restrain market growth
3.3 Opportunities
3.3.1 Emerging business segments and economies
3.3.2 Increasing outsourcing activities by major pharmaceutical companies towards emerging markets for cost savings
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weaknesses
3.4.3 Opportunities
3.4.4 Threats
3.5 Porter’s Five Forces Analysis
3.5.1 Buyer Power
3.5.2 Supplier Power
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitute
3.5.5 Threat of New Entrants
3.6 PEST Analysis
3.6.1 Political Factors Impacting CMO of Sterile Injectable Drugs Market
3.6.2 Economic Factors Impacting CMO of Sterile Injectable Drugs Market
3.6.3 Social Factors Impacting CMO of Sterile Injectable Drugs Market
3.6.4 Technological Factors Impacting CMO of Sterile Injectable Drugs Market
4 CMO of Sterile Injectable Drugs Market by Molecule Type
4.1 Small Molecule Segment Market Forecast, 2021-2031
4.1.1 Small Molecules Segment Market Overview
4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Large Molecule Segment Market Forecast, 2021-2031
4.2.1 Large Molecules Segment Market Overview
4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 CMO of Sterile Injectable Drugs Market by Type
5.1 Monoclonal Antibodies (mAbs) Segment Market Forecast, 2021-2031
5.1.1 Monoclonal Antibodies (mAbs) Segment Market Overview
5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 Cytokines Segment Market Forecast, 2021-2031
5.2.1 Cytokines Segment Market Overview
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.3 Insulin Segment Market Forecast, 2021-2031
5.3.1 Insulin Segment Market Overview
5.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.4 Peptide Hormones Segment Market Forecast, 2021-2031
5.4.1 Peptide Hormones Segment Market Overview
5.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.5 Vaccines Segment Market Forecast, 2021-2031
5.5.1 Vaccines Segment Market Overview
5.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.6 Immunoglobulins Segment Market Forecast, 2021-2031
5.6.1 Immunoglobulins Segment Market Overview
5.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.7 Blood Factors Segment Market Forecast, 2021-2031
5.7.1 Blood Factors Segment Market Overview
5.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.8 Peptide Antibiotics Segment Market Forecast, 2021-2031
5.8.1 Peptide Antibiotics Segment Market Overview
5.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.9 Others Segment Market Forecast, 2021-2031
5.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 CMO of Sterile Injectable Drugs Market by Application
6.1 Cancer Segment Market Forecast, 2021-2031
6.1.1 Cancer Segment Market Overview
6.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.2 Diabetes Segment Market Forecast, 2021-2031
6.2.1 Diabetes Segment Market Overview
6.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.3 Cardiovascular Diseases Segment Market Forecast, 2021-2031
6.3.1 Cardiovascular Diseases Segment Market Overview
6.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.4 CNS Segment Market Forecast, 2021-2031
6.4.1 CNS Segment Market Overview
6.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.5 Infectious Segment Market Forecast, 2021-2031
6.5.1 Infectious Segment Market Overview
6.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.6 Others Segment Market Forecast, 2021-2031
6.6.1 Others Segment Market Overview
6.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 CMO of Sterile Injectable Drugs Market by Container Type
7.1 Bottles Segment Market Forecast, 2021-2031
7.1.1 Bottles Segment Market Overview
7.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.2 Ampoules Segment Market Forecast, 2021-2031
7.2.1 Ampoules Segment Market Overview
7.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.3 Vials Segment Market Forecast, 2021-2031
7.3.1 Vials Segment Market Overview
7.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.4 Prefilled Syringes Segment Market Forecast, 2021-2031
7.4.1 Prefilled Syringes Segment Market Overview
7.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.5 Bags Segment Market Forecast, 2021-2031
7.5.1 Bags Segment Revenue, 2021-2031
7.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8 CMO of Sterile Injectable Drugs Market by Route of Administration
8.1 Subcutaneous (SC) Segment Market Forecast, 2021-2031
8.1.1 Subcutaneous (SC) Segment Revenue, 2021-2031
8.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8.2 Intravenous (IV) Segment Market Forecast, 2021-2031
8.2.1 Intravenous (IV) Segment Revenue, 2021-2031
8.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8.3 Intramuscular (IM) Segment Market Forecast, 2021-2031
8.3.1 Intramuscular Segment Revenue, 2021-2031
8.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8.4 Others Segment Market Forecast, 2021-2031
8.4.1 Others Segment Revenue, 2021-2031
8.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9 CMO of Sterile Injectable Drugs Market by Service
9.1 Bioanalytical Testing Segment Market Forecast, 2021-2031
9.1.1 Bioanalytical Testing Segment Revenue, 2021-2031
9.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9.2 Method Development & Validation Segment Market Forecast, 2021-2031
9.2.1 Method Development & Validation Segment Revenue, 2021-2031
9.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9.3 Stability Testing Segment Market Forecast, 2021-2031
9.3.1 Stability Testing Segment Revenue, 2021-2031
9.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9.4 Others Segment Market Forecast, 2021-2031
9.4.1 Others Segment Revenue, 2021-2031
9.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
10 Regional and Leading National CMO of Sterile Injectable Drugs Market Forecasts 2021-2031
10.1 Global CMO of Sterile Injectable Drugs Market by Region Forecast 2021-2031
10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
11 North America CMO of Sterile Injectable Drugs Market
11.1 North American CMO of Sterile Injectables Market Outlook
11.2 North America CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
11.3 North America CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
11.4 North America CMO of Sterile Injectable Drugs Market Forecast by Type
11.5 North America CMO of Sterile Injectable Drugs Market Forecast by Application
11.6 North America CMO of Sterile Injectable Drugs Market Forecast by Container Type
11.7 North America CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
11.8 North America CMO of Sterile Injectable Drugs Market Forecast by Service
11.9 U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
11.9.1 U.S. CMO of Sterile Injectables Market Outlook
11.9.2 U.S. CMO of Sterile Injectables Market Revenue, 2021-2031
11.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
11.10 Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
11.10.1 Canada CMO of Sterile Injectables Market Outlook
11.10.2 Canada CMO of Sterile Injectables Market Revenue, 2021-2031
11.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12 Europe CMO of Sterile Injectable Drugs Market
12.1 European CMO of Sterile Injectables Market Outlook
12.2 Europe CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
12.3 Europe CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
12.4 Europe CMO of Sterile Injectable Drugs Market Forecast by Type
12.5 Europe CMO of Sterile Injectable Drugs Market Forecast by Application
12.6 Europe CMO of Sterile Injectable Drugs Market Forecast by Container Type
12.7 Europe CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
12.8 Europe CMO of Sterile Injectable Drugs Market Forecast by Service
12.9 Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.9.1 Germany CMO of Sterile Injectables Market Outlook
12.9.2 Germany CMO of Sterile Injectables Market Revenue, 2021-2031
12.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.10 UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.10.1 UK CMO of Sterile Injectables Market Outlook
12.10.2 UK CMO of Sterile Injectables Market Revenue, 2021-2031
12.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.11 France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.11.1 France CMO of Sterile Injectables Market Outlook
12.11.2 France CMO of Sterile Injectables Market Revenue, 2021-2031
12.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.12 Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.12.1 Italy CMO of Sterile Injectables Market Outlook
12.12.2 Italy CMO of Sterile Injectables Market Revenue, 2021-2031
12.12.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.13 Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.13.1 Spain CMO of Sterile Injectables Market Outlook
12.13.2 Spain CMO of Sterile Injectables Market Revenue, 2021-2031
12.13.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.14 Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.14.1 Russia CMO of Sterile Injectables Market Outlook
12.14.2 Russia CMO of Sterile Injectables Market Revenue, 2021-2031
12.14.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.15 Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.15.1 Rest of Europe CMO of Sterile Injectables Market Outlook
12.15.2 Rest of Europe CMO of Sterile Injectables Market Revenue, 2021-2031
12.15.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13 Asia Pacific CMO of Sterile Injectable Drugs Market
13.1 Asia Pacific CMO of Sterile Injectables Market Outlook
13.2 Asia Pacific CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
13.3 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
13.4 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Type
13.5 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Application
13.6 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Container Type
13.7 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
13.8 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Service
13.9 Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.9.1 Japan CMO of Sterile Injectables Market Outlook
13.9.2 Japan CMO of Sterile Injectables Market Revenue, 2021-2031
13.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.10 China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.10.1 China CMO of Sterile Injectables Market Outlook
13.10.2 China CMO of Sterile Injectables Market Revenue, 2021-2031
13.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.11 India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.11.1 India CMO of Sterile Injectables Market Outlook
13.11.2 India CMO of Sterile Injectables Market Revenue, 2021-2031
13.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.12 Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.12.1 Australia CMO of Sterile Injectables Market Outlook
13.12.2 Australia CMO of Sterile Injectables Market Revenue, 2021-2031
13.12.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.13 South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.13.1 South-East Asia CMO of Sterile Injectables Market Revenue, 2021-2031
13.13.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.14 Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.14.1 Rest of Asia Pacific CMO of Sterile Injectables Market Outlook
13.14.2 Rest of Asia Pacific CMO of Sterile Injectables Market Revenue, 2021-2031
13.14.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14 Latin America CMO of Sterile Injectable Drugs Market
14.1 Latin American CMO of Sterile Injectables Market Outlook
14.2 Latin America CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
14.3 Latin America CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
14.4 Latin America CMO of Sterile Injectable Drugs Market Forecast by Type
14.5 Latin America CMO of Sterile Injectable Drugs Market Forecast by Application
14.6 Latin America CMO of Sterile Injectable Drugs Market Forecast by Container Type
14.7 Latin America CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
14.8 Latin America CMO of Sterile Injectable Drugs Market Forecast by Service
14.9 Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.9.1 Brazil CMO of Sterile Injectables Market Outlook
14.9.2 Brazil CMO of Sterile Injectables Market Revenue, 2021-2031
14.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.10 Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.10.1 Mexico CMO of Sterile Injectables Market Outlook
14.10.2 Mexico CMO of Sterile Injectables Market Revenue, 2021-2031
14.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.11 Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.11.1 Rest of Latin America CMO of Sterile Injectables Market Outlook
14.11.2 Rest of Latin America CMO of Sterile Injectables Market Revenue, 2021-2031
14.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15 Middle East and Africa CMO of Sterile Injectable Drugs Market
15.1 Middle East and Africa CMO of Sterile Injectables Market Outlook
15.2 Middle East and Africa CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
15.3 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
15.4 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Type
15.5 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Application
15.6 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Container Type
15.7 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
15.8 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Service
15.9 GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.9.1 GCC CMO of Sterile Injectables Market Outlook
15.9.2 GCC CMO of Sterile Injectables Market Revenue, 2021-2031
15.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.10 South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.10.1 South Africa CMO of Sterile Injectables Market Outlook
15.10.2 South Africa CMO of Sterile Injectables Market Revenue, 2021-2031
15.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.11 Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.11.1 Rest of MEA CMO of Sterile Injectables Market Outlook
15.11.2 Rest of MEA CMO of Sterile Injectables Market Revenue, 2021-2031
15.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
16 Company Profiles
16.1 Aenova Group
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Product Benchmarking
16.1.4 Recent Developments
16.2 Almac Group
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments
16.3 Baxter Biopharma Solutions
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.4 Product Benchmarking
16.3.5 Recent Developments
16.4 Boehringer Ingelheim
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.4 Product Benchmarking
16.5 Catalent, Inc.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Financial Analysis
16.5.4 Product Benchmarking
16.5.5 Recent Developments
16.6 CordenPharma
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Product Benchmarking
16.6.4 Recent Developments
16.7 Evonik Industries AG
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.4 Product Benchmarking
16.8 Famar Health Care Services
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Product Benchmarking
16.9 Fresenius Kabi Ag
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Financial Analysis
16.9.4 Product Benchmarking
16.10 Grifols SA
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.4 Product Benchmarking
16.10.5 Recent Developments
16.11 Hikma Pharmaceuticals PLC
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.4 Product Benchmarking
16.11.5 Recent Developments
16.12 Jubilant Pharmova Limited
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Financial Analysis
16.12.4 Product Benchmarking
16.13 Lonza
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Financial Analysis
16.13.4 Product Benchmarking
16.13.5 Recent Developments
16.14 Patheon, Inc. (Thermo Fischer)
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Financial Analysis
16.14.4 Product Benchmarking
16.15 Pfizer CentreOne
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Financial Analysis
16.15.4 Product Benchmarking
16.16 Recipharm AB
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Product Benchmarking
16.16.4 Recent Developments
16.17 Siegfried Holding AG
16.17.1 Company Snapshot
16.17.2 Company Overview
16.17.3 Financial Analysis
16.17.4 Product Benchmarking
17 Conclusion and Recommendations
17.1 Concluding Remarks
17.2 Recommendations
List of Tables
Table 1 Global CMO of Sterile Injectable Drugs Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global CMO of Sterile Injectables Market Forecast by Molecule Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 4 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 9 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global CMO of Sterile Injectables Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 14 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 15 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 16 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 17 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 18 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 19 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 20 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 25 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 30 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 31 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 32 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 33 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 34 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 35 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 36 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 37 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 38 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 39 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 40 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 41 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 42 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 43 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 44 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 45 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 46 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 47 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 48 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 49 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 50 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 51 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 52 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 53 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 54 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 55 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 56 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Global CMO of Sterile Injectables Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 60 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 61 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 62 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 63 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 64 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 65 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 66 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 67 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 68 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 69 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 70 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 71 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 72 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 73 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 74 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 75 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 76 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 77 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 78 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 79 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 80 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 81 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 82 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 83 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 84 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 85 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 86 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 87 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 88 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 89 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 90 Global CMO of Sterile Injectables Market Forecast by Container Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 91 Global CMO of Sterile Injectables Market Forecast for Bottles Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 92 Global CMO of Sterile Injectables Market Forecast for Bottles Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 93 Global CMO of Sterile Injectables Market Forecast for Bottles Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 94 Global CMO of Sterile Injectables Market Forecast for Bottles Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 95 Global CMO of Sterile Injectables Market Forecast for Bottles Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 96 Global CMO of Sterile Injectables Market Forecast for Ampoules Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 97 Global CMO of Sterile Injectables Market Forecast for Ampoules Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 98 Global CMO of Sterile Injectables Market Forecast for Ampoules Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 99 Global CMO of Sterile Injectables Market Forecast for Ampoules Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 100 Global CMO of Sterile Injectables Market Forecast for Ampoules Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 101 Global CMO of Sterile Injectables Market Forecast for Vials Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 102 Global CMO of Sterile Injectables Market Forecast for Vials Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 103 Global CMO of Sterile Injectables Market Forecast for Vials Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 104 Global CMO of Sterile Injectables Market Forecast for Vials Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 105 Global CMO of Sterile Injectables Market Forecast for Vials Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 106 Global CMO of Sterile Injectables Market Forecast for Prefilled Syringes Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 107 Global CMO of Sterile Injectables Market Forecast for Prefilled Syringes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 108 Global CMO of Sterile Injectables Market Forecast for Prefilled Syringes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 109 Global CMO of Sterile Injectables Market Forecast for Prefilled Syringes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 110 Global CMO of Sterile Injectables Market Forecast for Prefilled Syringes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 111 Global CMO of Sterile Injectables Market Forecast for Bags Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 112 Global CMO of Sterile Injectables Market Forecast for Bags Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 113 Global CMO of Sterile Injectables Market Forecast for Bags Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 114 Global CMO of Sterile Injectables Market Forecast for Bags Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 115 Global CMO of Sterile Injectables Market Forecast for Bags Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 116 Global CMO of Sterile Injectables Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 117 Global CMO of Sterile Injectables Market Forecast for Subcutaneous (SC) Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 118 Global CMO of Sterile Injectables Market Forecast for Subcutaneous (SC) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 119 Global CMO of Sterile Injectables Market Forecast for Subcutaneous (SC) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 120 Global CMO of Sterile Injectables Market Forecast for Subcutaneous (SC) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 121 Global CMO of Sterile Injectables Market Forecast for Subcutaneous (SC) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 122 Global CMO of Sterile Injectables Market Forecast for Intravenous (IV) Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 123 Global CMO of Sterile Injectables Market Forecast for Intravenous (IV) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 124 Global CMO of Sterile Injectables Market Forecast for Intravenous (IV) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 125 Global CMO of Sterile Injectables Market Forecast for Intravenous (IV) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 126 Global CMO of Sterile Injectables Market Forecast for Intravenous (IV) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 127 Global CMO of Sterile Injectables Market Forecast for Intramuscular (IM) Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 128 Global CMO of Sterile Injectables Market Forecast for Intramuscular (IM) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 129 Global CMO of Sterile Injectables Market Forecast for Intramuscular (IM) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 130 Global CMO of Sterile Injectables Market Forecast for Intramuscular (IM) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 131 Global CMO of Sterile Injectables Market Forecast for Intramuscular (IM) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 132 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 133 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 134 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 135 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 136 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 137 Global CMO of Sterile Injectables Market Forecast by Service, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 138 Global CMO of Sterile Injectables Market Forecast for Bioanalytical Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 139 Global CMO of Sterile Injectables Market Forecast for Bioanalytical Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 140 Global CMO of Sterile Injectables Market Forecast for Bioanalytical Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 141 Global CMO of Sterile Injectables Market Forecast for Bioanalytical Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 142 Global CMO of Sterile Injectables Market Forecast for Bioanalytical Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 143 Global CMO of Sterile Injectables Market Forecast for Method Development & Validation Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 144 Global CMO of Sterile Injectables Market Forecast for Method Development & Validation Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 145 Global CMO of Sterile Injectables Market Forecast for Method Development & Validation Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 146 Global CMO of Sterile Injectables Market Forecast for Method Development & Validation Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 147 Global CMO of Sterile Injectables Market Forecast for Method Development & Validation Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 148 Global CMO of Sterile Injectables Market Forecast for Stability Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 149 Global CMO of Sterile Injectables Market Forecast for Stability Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 150 Global CMO of Sterile Injectables Market Forecast for Stability Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 151 Global CMO of Sterile Injectables Market Forecast for Stability Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 152 Global CMO of Sterile Injectables Market Forecast for Stability Testing Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 153 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 154 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 155 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 156 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 157 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 158 Global CMO of Sterile Injectables Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%)
Table 159 Global CMO of Sterile Injectables Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 160 Global CMO of Sterile Injectables Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 161 Global CMO of Sterile Injectables Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 162 Global CMO of Sterile Injectables Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 163 North America CMO of Sterile Injectables Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 164 North America CMO of Sterile Injectables Market Forecast by Molecule Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 165 North America CMO of Sterile Injectables Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 166 North America CMO of Sterile Injectables Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 167 North America CMO of Sterile Injectables Market Forecast by Container Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 168 North America CMO of Sterile Injectables Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 169 North America CMO of Sterile Injectables Market Forecast by Service, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 170 U.S. CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 171 U.S. CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 172 U.S. CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 173 U.S. CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 174 U.S. CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 175 Canada CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 176 Canada CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 177 Canada CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 178 Canada CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 179 Canada CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 180 Europe CMO of Sterile Injectables Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 181 Europe CMO of Sterile Injectables Market Forecast by Molecule Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 182 Europe CMO of Sterile Injectables Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 183 Europe CMO of Sterile Injectables Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 184 Europe CMO of Sterile Injectables Market Forecast by Container Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 185 Europe CMO of Sterile Injectables Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 186 Europe CMO of Sterile Injectables Market Forecast by Service, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 187 Germany CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 188 Germany CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 189 Germany CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 190 Germany CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 191 Germany CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 192 UK CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 193 UK CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 194 UK CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 195 UK CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 196 France CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 197 France CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 198 France CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 199 France CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 200 France CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 201 France CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 202 Italy CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 203 Italy CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 204 Italy CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 205 Italy CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 206 Italy CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 207 Spain CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 208 Spain CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 209 Spain CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 210 Spain CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 211 Spain CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 212 Russia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 213 Russia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 214 Russia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 215 Russia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 216 Russia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 217 Rest of Europe CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 218 Rest of Europe CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 219 Rest of Europe CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 220 Rest of Europe CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 221 Rest of Europe CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 222 Asia Pacific CMO of Sterile Injectables Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 223 Asia Pacific CMO of Sterile Injectables Market Forecast by Molecule Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 224 Asia Pacific CMO of Sterile Injectables Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 225 Asia Pacific CMO of Sterile Injectables Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 226 Asia Pacific CMO of Sterile Injectables Market Forecast by Container Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 227 Asia Pacific CMO of Sterile Injectables Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 228 Asia Pacific CMO of Sterile Injectables Market Forecast by Service, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 229 Japan CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 230 Japan CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 231 Japan CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 232 Japan CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 233 Japan CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 234 China CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 235 China CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 236 China CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 237 China CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 238 China CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 239 India CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 240 India CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 241 India CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 242 India CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 243 India CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 244 Australia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 245 Australia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 246 Australia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 247 Australia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 248 Australia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 249 South-East Asia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 250 South-East Asia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 251 South-East Asia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 252 South-East Asia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 253 South-East Asia CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 254 Rest of Asia Pacific CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 255 Rest of Asia Pacific CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 256 Rest of Asia Pacific CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 257 Rest of Asia Pacific CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 258 Rest of Asia Pacific CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 259 Latin America CMO of Sterile Injectables Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 260 Latin America CMO of Sterile Injectables Market Forecast by Molecule Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 261 Latin America CMO of Sterile Injectables Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 262 Latin America CMO of Sterile Injectables Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 263 Latin America CMO of Sterile Injectables Market Forecast by Container Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 264 Latin America CMO of Sterile Injectables Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 265 Latin America CMO of Sterile Injectables Market Forecast by Service, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 266 Brazil CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 267 Brazil CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 268 Brazil CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 269 Brazil CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 270 Brazil CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 271 Mexico CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 272 Mexico CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 273 Mexico CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 274 Mexico CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 275 Mexico CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 276 Rest of Latin America CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 277 Rest of Latin America CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 278 Rest of Latin America CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 279 Rest of Latin America CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 280 Rest of Latin America CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 281 MEA CMO of Sterile Injectables Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 282 MEA CMO of Sterile Injectables Market Forecast by Molecule Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 283 MEA CMO of Sterile Injectables Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 284 MEA CMO of Sterile Injectables Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 285 MEA CMO of Sterile Injectables Market Forecast by Container Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 286 MEA CMO of Sterile Injectables Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 287 MEA CMO of Sterile Injectables Market Forecast by Service, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 288 GCC CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 289 GCC CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 290 GCC CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 291 GCC CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 292 GCC CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 293 South Africa CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 294 South Africa CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 295 South Africa CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 296 South Africa CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 297 South Africa CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 298 Rest of MEA CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 299 Rest of MEA CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 300 Rest of MEA CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 301 Rest of MEA CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 302 Rest of MEA CMO of Sterile Injectables Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 303 Aenova Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 304 Aenova Group: Product Benchmarking
Table 305 Aenova Group: Recent Developments
Table 306 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 307 Almac Group: Product Benchmarking
Table 308 Almac Group: Recent Developments
Table 309 Baxter Biopharma Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 310 Baxter Biopharma Solutions: Product Benchmarking
Table 311 Baxter Biopharma Solutions: Recent Developments
Table 312 Boehringer Ingelheim: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 313 Boehringer Ingelheim: Product Benchmarking
Table 314 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 315 Catalent, Inc.: Product Benchmarking
Table 316 Catalent, Inc.: Recent Developments
Table 317 CordenPharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 318 CordenPharma: Product Benchmarking
Table 319 CordenPharma: Recent Developments
Table 320 Evonik Industries AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 321 Evonik Industries AG: Product Benchmarking
Table 322 Famar Health Care Services: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 323 Famar Health Care Services: Product Benchmarking
Table 324 Fresenius Kabi Ag: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 325 Fresenius Kabi Ag: Product Benchmarking
Table 326 Grifols SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 327 Grifols SA: Product Benchmarking
Table 328 Grifols SA: Recent Developments
Table 329 Hikma Pharmaceuticals PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 330 Hikma Pharmaceuticals PLC: Product Benchmarking
Table 331 Hikma Pharmaceuticals PLC: Recent Developments
Table 332 Jubilant Pharmova Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 333 Jubilant Pharmova Limited: Product Benchmarking
Table 334 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 335 Lonza: Product Benchmarking
Table 336 Lonza: Recent Developments
Table 337 Patheon, Inc. (Thermo Fischer): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 338 Patheon, Inc. (Thermo Fischer): Product Benchmarking
Table 339 Pfizer CentreOne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 340 Pfizer CentreOne: Product Benchmarking
Table 341 Recipharm AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 342 Recipharm AB: Product Benchmarking
Table 343 Recipharm AB: Recent Developments
Table 344 Siegfried Holding AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 345 Siegfried Holding AG: Product Benchmarking
List of Figures
Figure 1 Global CMO of Sterile Injectable Drugs Market: Market Segmentation
Figure 2 Global CMO of Sterile Injectable Drugs Market: Market Trends
Figure 3 Global CMO of Sterile Injectable Drugs Market: SWOT Analysis
Figure 4 Porter’s Analysis
Figure 5 PEST Analysis
Figure 6 Global CMO of Sterile Injectable Drugs Market Forecast by Molecule Type, 2021-2031 (US$ million, AGR %)
Figure 7 Global CMO of Sterile Injectable Drugs Market Share Forecast by Molecule Type, 2021, 2026, 2031 (%)
Figure 8 Global CMO of Sterile Injectable Drugs Market for Small Molecule Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 9 Global CMO of Sterile Injectable Drugs Market for Small Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 10 Global CMO of Sterile Injectable Drugs Market for Small Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 11 Global CMO of Sterile Injectable Drugs Market for Small Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 12 Global CMO of Sterile Injectable Drugs Market for Small Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 13 Global CMO of Sterile Injectable Drugs Market for Large Molecule Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 14 Global CMO of Sterile Injectable Drugs Market for Large Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 15 Global CMO of Sterile Injectable Drugs Market for Large Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 16 Global CMO of Sterile Injectable Drugs Market for Large Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 17 Global CMO of Sterile Injectable Drugs Market for Large Molecule Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 18 Global CMO of Sterile Injectable Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR %)
Figure 19 Global CMO of Sterile Injectable Drugs Market Share Forecast by Type, 2021, 2026, 2031 (%)
Figure 20 Global CMO of Sterile Injectable Drugs Market for Monoclonal Antibodies (mAbs) Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 21 Global CMO of Sterile Injectable Drugs Market for Monoclonal Antibodies (mAbs) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 22 Global CMO of Sterile Injectable Drugs Market for Monoclonal Antibodies (mAbs) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 23 Global CMO of Sterile Injectable Drugs Market for Monoclonal Antibodies (mAbs) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 24 Global CMO of Sterile Injectable Drugs Market for Monoclonal Antibodies (mAbs) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 25 Global CMO of Sterile Injectable Drugs Market for Cytokines Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 26 Global CMO of Sterile Injectable Drugs Market for Cytokines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 27 Global CMO of Sterile Injectable Drugs Market for Cytokines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 28 Global CMO of Sterile Injectable Drugs Market for Cytokines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 29 Global CMO of Sterile Injectable Drugs Market for Cytokines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 30 Global CMO of Sterile Injectable Drugs Market for Insulin Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 31 Global CMO of Sterile Injectable Drugs Market for Insulin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 32 Global CMO of Sterile Injectable Drugs Market for Insulin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 33 Global CMO of Sterile Injectable Drugs Market for Insulin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 34 Global CMO of Sterile Injectable Drugs Market for Insulin Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 35 Global CMO of Sterile Injectable Drugs Market for Peptide Hormones Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 36 Global CMO of Sterile Injectable Drugs Market for Peptide Hormones Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 37 Global CMO of Sterile Injectable Drugs Market for Peptide Hormones Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 38 Global CMO of Sterile Injectable Drugs Market for Peptide Hormones Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 39 Global CMO of Sterile Injectable Drugs Market for Peptide Hormones Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 40 Global CMO of Sterile Injectable Drugs Market for Vaccines Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 41 Global CMO of Sterile Injectable Drugs Market for Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 42 Global CMO of Sterile Injectable Drugs Market for Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 43 Global CMO of Sterile Injectable Drugs Market for Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 44 Global CMO of Sterile Injectable Drugs Market for Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 45 Global CMO of Sterile Injectable Drugs Market for Immunoglobulins Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 46 Global CMO of Sterile Injectable Drugs Market for Immunoglobulins Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 47 Global CMO of Sterile Injectable Drugs Market for Immunoglobulins Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 48 Global CMO of Sterile Injectable Drugs Market for Immunoglobulins Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 49 Global CMO of Sterile Injectable Drugs Market for Immunoglobulins Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 50 Global CMO of Sterile Injectable Drugs Market for Blood Factors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 51 Global CMO of Sterile Injectable Drugs Market for Blood Factors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 52 Global CMO of Sterile Injectable Drugs Market for Blood Factors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 53 Global CMO of Sterile Injectable Drugs Market for Blood Factors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 54 Global CMO of Sterile Injectable Drugs Market for Blood Factors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 55 Global CMO of Sterile Injectable Drugs Market for Peptide Antibiotics Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 56 Global CMO of Sterile Injectable Drugs Market for Peptide Antibiotics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 57 Global CMO of Sterile Injectable Drugs Market for Peptide Antibiotics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 58 Global CMO of Sterile Injectable Drugs Market for Peptide Antibiotics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 59 Global CMO of Sterile Injectable Drugs Market for Peptide Antibiotics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 60 Global CMO of Sterile Injectable Drugs Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 61 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 62 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 63 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 64 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 65 Global CMO of Sterile Injectable Drugs Market Forecast by Application, 2021-2031 (US$ million, AGR %)
Figure 66 Global CMO of Sterile Injectable Drugs Market Share Forecast by Application, 2021, 2026, 2031 (%)
Figure 67 Global CMO of Sterile Injectable Drugs Market for Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 68 Global CMO of Sterile Injectable Drugs Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 69 Global CMO of Sterile Injectable Drugs Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 70 Global CMO of Sterile Injectable Drugs Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 71 Global CMO of Sterile Injectable Drugs Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 72 Global CMO of Sterile Injectable Drugs Market for Diabetes Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 73 Global CMO of Sterile Injectable Drugs Market for Diabetes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 74 Global CMO of Sterile Injectable Drugs Market for Diabetes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 75 Global CMO of Sterile Injectable Drugs Market for Diabetes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 76 Global CMO of Sterile Injectable Drugs Market for Diabetes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 77 Global CMO of Sterile Injectable Drugs Market for Cardiovascular Diseases Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 78 Global CMO of Sterile Injectable Drugs Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 79 Global CMO of Sterile Injectable Drugs Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 80 Global CMO of Sterile Injectable Drugs Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 81 Global CMO of Sterile Injectable Drugs Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 82 Global CMO of Sterile Injectable Drugs Market for CNS Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 83 Global CMO of Sterile Injectable Drugs Market for CNS Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 84 Global CMO of Sterile Injectable Drugs Market for CNS Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 85 Global CMO of Sterile Injectable Drugs Market for CNS Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 86 Global CMO of Sterile Injectable Drugs Market for CNS Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 87 Global CMO of Sterile Injectable Drugs Market for Infectious Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 88 Global CMO of Sterile Injectable Drugs Market for Infectious Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 89 Global CMO of Sterile Injectable Drugs Market for Infectious Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 90 Global CMO of Sterile Injectable Drugs Market for Infectious Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 91 Global CMO of Sterile Injectable Drugs Market for Infectious Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 92 Global CMO of Sterile Injectable Drugs Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 93 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 94 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 95 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 96 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 97 Global CMO of Sterile Injectable Drugs Market Forecast by Container Type, 2021-2031 (US$ million, AGR %)
Figure 98 Global CMO of Sterile Injectable Drugs Market Share Forecast by Container Type, 2021, 2026, 2031 (%)
Figure 99 Global CMO of Sterile Injectable Drugs Market for Bottles Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 100 Global CMO of Sterile Injectable Drugs Market for Bottles Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 101 Global CMO of Sterile Injectable Drugs Market for Bottles Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 102 Global CMO of Sterile Injectable Drugs Market for Bottles Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 103 Global CMO of Sterile Injectable Drugs Market for Bottles Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 104 Global CMO of Sterile Injectable Drugs Market for Ampoules Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 105 Global CMO of Sterile Injectable Drugs Market for Ampoules Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 106 Global CMO of Sterile Injectable Drugs Market for Ampoules Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 107 Global CMO of Sterile Injectable Drugs Market for Ampoules Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 108 Global CMO of Sterile Injectable Drugs Market for Ampoules Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 109 Global CMO of Sterile Injectable Drugs Market for Vials Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 110 Global CMO of Sterile Injectable Drugs Market for Vials Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 111 Global CMO of Sterile Injectable Drugs Market for Vials Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 112 Global CMO of Sterile Injectable Drugs Market for Vials Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 113 Global CMO of Sterile Injectable Drugs Market for Vials Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 114 Global CMO of Sterile Injectable Drugs Market for Prefilled Syringes Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 115 Global CMO of Sterile Injectable Drugs Market for Prefilled Syringes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 116 Global CMO of Sterile Injectable Drugs Market for Prefilled Syringes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 117 Global CMO of Sterile Injectable Drugs Market for Prefilled Syringes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 118 Global CMO of Sterile Injectable Drugs Market for Prefilled Syringes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 119 Global CMO of Sterile Injectable Drugs Market for Bags Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 120 Global CMO of Sterile Injectable Drugs Market for Bags Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 121 Global CMO of Sterile Injectable Drugs Market for Bags Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 122 Global CMO of Sterile Injectable Drugs Market for Bags Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 123 Global CMO of Sterile Injectable Drugs Market for Bags Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 124 Global CMO of Sterile Injectable Drugs Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR %)
Figure 125 Global CMO of Sterile Injectable Drugs Market Share Forecast by Route of Administration, 2021, 2026, 2031 (%)
Figure 126 Global CMO of Sterile Injectable Drugs Market for Subcutaneous (SC) Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 127 Global CMO of Sterile Injectable Drugs Market for Subcutaneous (SC) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 128 Global CMO of Sterile Injectable Drugs Market for Subcutaneous (SC) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 129 Global CMO of Sterile Injectable Drugs Market for Subcutaneous (SC) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 130 Global CMO of Sterile Injectable Drugs Market for Subcutaneous (SC) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 131 Global CMO of Sterile Injectable Drugs Market for Intravenous (IV) Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 132 Global CMO of Sterile Injectable Drugs Market for Intravenous (IV) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 133 Global CMO of Sterile Injectable Drugs Market for Intravenous (IV) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 134 Global CMO of Sterile Injectable Drugs Market for Intravenous (IV) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 135 Global CMO of Sterile Injectable Drugs Market for Intravenous (IV) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 136 Global CMO of Sterile Injectable Drugs Market for Intramuscular (IM) Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 137 Global CMO of Sterile Injectable Drugs Market for Intramuscular (IM) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 138 Global CMO of Sterile Injectable Drugs Market for Intramuscular (IM) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 139 Global CMO of Sterile Injectable Drugs Market for Intramuscular (IM) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 140 Global CMO of Sterile Injectable Drugs Market for Intramuscular (IM) Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 141 Global CMO of Sterile Injectable Drugs Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 142 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 143 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 144 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 145 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 146 Global CMO of Sterile Injectable Drugs Market Forecast by Service, 2021-2031 (US$ million, AGR %)
Figure 147 Global CMO of Sterile Injectable Drugs Market Share Forecast by Service, 2021, 2026, 2031 (%)
Figure 148 Global CMO of Sterile Injectable Drugs Market for Bioanalytical Testing Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 149 Global CMO of Sterile Injectable Drugs Market for Bioanalytical Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 150 Global CMO of Sterile Injectable Drugs Market for Bioanalytical Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 151 Global CMO of Sterile Injectable Drugs Market for Bioanalytical Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 152 Global CMO of Sterile Injectable Drugs Market for Bioanalytical Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 153 Global CMO of Sterile Injectable Drugs Market for Method Development & Validation Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 154 Global CMO of Sterile Injectable Drugs Market for Method Development & Validation Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 155 Global CMO of Sterile Injectable Drugs Market for Method Development & Validation Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 156 Global CMO of Sterile Injectable Drugs Market for Method Development & Validation Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 157 Global CMO of Sterile Injectable Drugs Market for Method Development & Validation Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 158 Global CMO of Sterile Injectable Drugs Market for Stability Testing Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 159 Global CMO of Sterile Injectable Drugs Market for Stability Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 160 Global CMO of Sterile Injectable Drugs Market for Stability Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 161 Global CMO of Sterile Injectable Drugs Market for Stability Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 162 Global CMO of Sterile Injectable Drugs Market for Stability Testing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 163 Global CMO of Sterile Injectable Drugs Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 164 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 165 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 166 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 167 Global CMO of Sterile Injectable Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 168 Global CMO of Sterile Injectable Drugs Market Forecast by Region 2021-2031 (US$ million)
Figure 169 Global CMO of Sterile Injectable Drugs Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 170 Global CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 171 Global CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 172 Global CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 173 Global CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 174 North America CMO of Sterile Injectable Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 175 North America CMO of Sterile Injectable Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 176 North America CMO of Sterile Injectable Drugs Market Forecast by Molecule Type, 2021-2031 (US$ million, AGR%)
Figure 177 North America CMO of Sterile Injectable Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 178 North America CMO of Sterile Injectable Drugs Market Forecast by Application, 2021-2031 (US$ million, AGR%)
Figure 179 North America CMO of Sterile Injectable Drugs Market Forecast by Container Type, 2021-2031 (US$ million, AGR%)
Figure 180 North America CMO of Sterile Injectable Drugs Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 181 North America CMO of Sterile Injectable Drugs Market Forecast by Service, 2021-2031 (US$ million, AGR%)
Figure 182 U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 183 U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 184 U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 185 U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 186 U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 187 Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 188 Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 189 Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 190 Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 191 Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 192 Europe CMO of Sterile Injectable Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 193 Europe CMO of Sterile Injectable Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 194 Europe CMO of Sterile Injectable Drugs Market Forecast by Molecule Type, 2021-2031 (US$ million, AGR%)
Figure 195 Europe CMO of Sterile Injectable Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 196 Europe CMO of Sterile Injectable Drugs Market Forecast by Application, 2021-2031 (US$ million, AGR%)
Figure 197 Europe CMO of Sterile Injectable Drugs Market Forecast by Container Type, 2021-2031 (US$ million, AGR%)
Figure 198 Europe CMO of Sterile Injectable Drugs Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 199 Europe CMO of Sterile Injectable Drugs Market Forecast by Service, 2021-2031 (US$ million, AGR%)
Figure 200 Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 201 Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 202 Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 203 Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 204 Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 205 UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 206 UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 207 UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 208 UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 209 UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 210 France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 211 France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 212 France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 213 France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 214 France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 215 Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 216 Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 217 Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 218 Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 219 Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 220 Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 221 Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 222 Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 223 Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 224 Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 225 Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 226 Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 227 Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 228 Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 229 Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 230 Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 231 Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 232 Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 233 Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 234 Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 235 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 236 Asia Pacific CMO of Sterile Injectable Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 237 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Molecule Type, 2021-2031 (US$ million, AGR%)
Figure 238 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 239 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Application, 2021-2031 (US$ million, AGR%)
Figure 240 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Container Type, 2021-2031 (US$ million, AGR%)
Figure 241 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 242 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Service, 2021-2031 (US$ million, AGR%)
Figure 243 Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 244 Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 245 Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 246 Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 247 Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 248 China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 249 China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 250 China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 251 China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 252 China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 253 India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 254 India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 255 India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 256 India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 257 India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 258 Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 259 Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 260 Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 261 Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 262 Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 263 South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 264 South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 265 South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 266 South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 267 South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 268 Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 269 Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 270 Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 271 Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 272 Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 273 Latin America CMO of Sterile Injectable Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 274 Latin America CMO of Sterile Injectable Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 275 Latin America CMO of Sterile Injectable Drugs Market Forecast by Molecule Type, 2021-2031 (US$ million, AGR%)
Figure 276 Latin America CMO of Sterile Injectable Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 277 Latin America CMO of Sterile Injectable Drugs Market Forecast by Application, 2021-2031 (US$ million, AGR%)
Figure 278 Latin America CMO of Sterile Injectable Drugs Market Forecast by Container Type, 2021-2031 (US$ million, AGR%)
Figure 279 Latin America CMO of Sterile Injectable Drugs Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 280 Latin America CMO of Sterile Injectable Drugs Market Forecast by Service, 2021-2031 (US$ million, AGR%)
Figure 281 Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 282 Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 283 Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 284 Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 285 Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 286 Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 287 Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 288 Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 289 Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 290 Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 291 Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 292 Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 293 Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 294 Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 295 Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 296 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 297 Middle East and Africa CMO of Sterile Injectable Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 298 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Molecule Type, 2021-2031 (US$ million, AGR%)
Figure 299 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 300 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Application, 2021-2031 (US$ million, AGR%)
Figure 301 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Container Type, 2021-2031 (US$ million, AGR%)
Figure 302 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 303 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Service, 2021-2031 (US$ million, AGR%)
Figure 304 GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 305 GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 306 GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 307 GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 308 GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 309 South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 310 South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 311 South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 312 South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 313 South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 314 Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 315 Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 316 Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 317 Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 318 Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 319 Baxter Biopharma Solutions: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 320 Baxter Biopharma Solutions: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 321 Baxter Biopharma Solutions: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 322 Boehringer Ingelheim: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 323 Boehringer Ingelheim: R&D Expenses, 2017-2020 (US$ million, AGR%)
Figure 324 Boehringer Ingelheim: Gross Profit, 2017-2020 (US$ million, AGR%)
Figure 325 Catalent, Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 326 Catalent, Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 327 Evonik Industries AG: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 328 Evonik Industries AG: R&D Expenses, 2016-2020 (US$ million, AGR%)
Figure 329 Fresenius Kabi Ag: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 330 Fresenius Kabi Ag: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 331 Fresenius Kabi Ag: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 332 Grifols SA: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 333 Grifols SA: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 334 Grifols SA: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 335 Hikma Pharmaceuticals PLC: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 336 Hikma Pharmaceuticals PLC: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 337 Hikma Pharmaceuticals PLC: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 338 Jubilant Pharmova Limited: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 339 Lonza: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 340 Lonza: R&D Expenses, 2017-2020 (US$ million, AGR%)
Figure 341 Lonza: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 342 Patheon, Inc. (Thermo Fischer): Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 343 Patheon, Inc. (Thermo Fischer): R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 344 Patheon, Inc. (Thermo Fischer): Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 345 Pfizer CentreOne: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 346 Pfizer CentreOne: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 347 Pfizer CentreOne: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 348 Siegfried Holding AG: Net Revenue, 2017-2020 (US$ million, AGR%)
Companies Profiled in the Report
Aenova Group
Almac Group
Baxter Biopharma Solutions
Boehringer Ingelheim
Catalent, Inc.
CordenPharma
Evonik Industries AG
Famar Health Care Services
Fresenius Kabi Ag
Grifols SA
Hikma Pharmaceuticals PLC
Jubilant Pharmova Limited
Lonza
Patheon, Inc. (Thermo Fischer)
Pfizer CentreOne
Recipharm AB
Siegfried Holding AG
List of Other Companies
Actavis
ADC Biotechnology
Aegerion Pharmaceuticals
Aesica Pharma
Alexion Pharmaceuticals
Almac Group
Astellas
Boehringer Ingelheim
Bristol-Myers Squibb Company
Bushu Pharmaceuticals
Cambrex
Catalent Pharma Solutions
Cipla
CordenPharma
CTC Bio
Daito Pharmaceutical
Delpharm
DPx Holdings B.V.
Dr. Reddy's Laboratories
Eisai
Eli Lilly
FUJIFILM Diosynth Biotechnologies,
G-CON
Gallus Biopharmaceutical, LLC.
GlaxoSmithKline (GSK)
Indian Pharmaceutical Alliance
Innovent Biologics
IRIX Pharmaceuticals
Janssen
JK Pharmaceutical
Johnson & Johnson
Lonza
Lupin
Marinopoulos Group
Matrix Laboratories
Medice
Medichem
Merck & Co.
Mylan
Neuland Laboratories
Orchid Chemicals & Pharmaceuticals
Oxford Biomedica
Patheon
Pfizer
Progenics
Recepta Biopharma
Recipharm
Roche
Samsung Bioepis
Shire
SMS Pharmaceuticals
Takeda
Valeant Pharmaceuticals
West Pharmaceutical Services
WuXi PharmaTech
List of Organizations
Association of British Pharmaceutical Industry (ABPI)
Central Drugs Standard Control Organization (CDSCO)
Department of Health and Family Welfare
Development and Reform Commission (NDRC)
European Commission
European Medicines Agency (EMA)
Food and Drug Administration (US FDA)
Indian Drug Manufacturer's Association (IDMA)
International Society of Pharmaceutical Engineering (IPSE)
Korea Food and Drug Administration (KFDA)
Korea Pharmaceutical Manufacturer's Association (KPMA)
Medicines and Healthcare Products Regulatory Agency (MHRA)
Medicines Manufacturing Industry Partnership (MMIP)
Ministry of Health (MOH)
Ministry of Health, Labor and Welfare (MHLW)
Ministry of Industry and Information Technology (MIIT)
Pharmaceutical and Medical Devices Agency (PMDA)
World Health Organization (WHO)
Aenova Group
Almac Group
Baxter Biopharma Solutions
Boehringer Ingelheim
Catalent, Inc.
CordenPharma
Evonik Industries AG
Famar Health Care Services
Fresenius Kabi Ag
Grifols SA
Hikma Pharmaceuticals PLC
Jubilant Pharmova Limited
Lonza
Patheon, Inc. (Thermo Fischer)
Pfizer CentreOne
Recipharm AB
Siegfried Holding AG
List of Other Companies
Actavis
ADC Biotechnology
Aegerion Pharmaceuticals
Aesica Pharma
Alexion Pharmaceuticals
Almac Group
Astellas
Boehringer Ingelheim
Bristol-Myers Squibb Company
Bushu Pharmaceuticals
Cambrex
Catalent Pharma Solutions
Cipla
CordenPharma
CTC Bio
Daito Pharmaceutical
Delpharm
DPx Holdings B.V.
Dr. Reddy's Laboratories
Eisai
Eli Lilly
FUJIFILM Diosynth Biotechnologies,
G-CON
Gallus Biopharmaceutical, LLC.
GlaxoSmithKline (GSK)
Indian Pharmaceutical Alliance
Innovent Biologics
IRIX Pharmaceuticals
Janssen
JK Pharmaceutical
Johnson & Johnson
Lonza
Lupin
Marinopoulos Group
Matrix Laboratories
Medice
Medichem
Merck & Co.
Mylan
Neuland Laboratories
Orchid Chemicals & Pharmaceuticals
Oxford Biomedica
Patheon
Pfizer
Progenics
Recepta Biopharma
Recipharm
Roche
Samsung Bioepis
Shire
SMS Pharmaceuticals
Takeda
Valeant Pharmaceuticals
West Pharmaceutical Services
WuXi PharmaTech
List of Organizations
Association of British Pharmaceutical Industry (ABPI)
Central Drugs Standard Control Organization (CDSCO)
Department of Health and Family Welfare
Development and Reform Commission (NDRC)
European Commission
European Medicines Agency (EMA)
Food and Drug Administration (US FDA)
Indian Drug Manufacturer's Association (IDMA)
International Society of Pharmaceutical Engineering (IPSE)
Korea Food and Drug Administration (KFDA)
Korea Pharmaceutical Manufacturer's Association (KPMA)
Medicines and Healthcare Products Regulatory Agency (MHRA)
Medicines Manufacturing Industry Partnership (MMIP)
Ministry of Health (MOH)
Ministry of Health, Labor and Welfare (MHLW)
Ministry of Industry and Information Technology (MIIT)
Pharmaceutical and Medical Devices Agency (PMDA)
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031Related reports
Clinical Trial Supplies Market Report 2021-2031
Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance...Full DetailsPublished: 11 October 2021Pharmaceutical Contract Manufacturing Market Report 2022-2032
The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D,...Full DetailsPublished: 13 April 2022Single-Cell Analysis Market Report 2022-2032
The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a...Full DetailsPublished: 26 May 2022Influenza Vaccines Market Report 2020-2030
For the companies operating in the global influenza vaccines market, there is an immense opportunity from emerging economies across the...Full DetailsPublished: 30 September 2020Topical Drug Delivery Market Report 2022-2032
Some of the factors driving the market growth are the increasing prevalence of skin and eye diseases, high incidences of...Full DetailsPublished: 26 January 2022Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021
Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry....Full DetailsPublished: 06 January 2021Contract Research Organisations (CROs) Market Report 2022-2032
The global Contract Research Organizations (CROs) market was valued at US$57.1 billion in 2021 and is projected to grow at...Full DetailsPublished: 12 August 2022Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022
Pharmaceutical CMOs market is projected to grow at a CAGR of 6.9% by 2032....Full DetailsPublished: 25 November 2022Pharmaceutical Spray Drying Market Report 2021-2031
The rising prevalence of oncological disorders, lung infections, rising demand for customised drugs coupled with new orphan diseases discoveries, are...Full DetailsPublished: 25 October 2021Decentralized Clinical Trials Market Report 2022-2032
Some of the factors driving the market growth are the rising geriatric population, increasing prevalence of cancer, and rising demand...Full DetailsPublished: 24 January 2022
Download sample pages
Complete the form below to download your free sample pages for Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes 3D Cell Culture and 3D Bioprinting Market Report 2023-2033
The global 3D Cell Culture and 3D Bioprinting market is valued at US$2,277.2 million in 2023 and is projected to grow at a CAGR of 17.8% during the forecast period 2023-2033.
03 October 2023
Visiongain Publishes Bioreactors Market Report 2023-2033
The global Bioreactors market was estimated to be valued at US$9,977.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.
29 September 2023
Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
27 September 2023
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
25 September 2023
